New Tool Helps Doctors Weigh Statin Risks vs. Heart Benefits

A new clinical tool has been developed to help doctors assess the risk of rare but serious muscle disorders in patients taking statins. The medication is widely prescribed to lower cholesterol and reduce the risk of heart attacks or strokes. Statins can cut LDL cholesterol by up to 60%, significantly lowering the chances of cardiovascular events. Yet fewer than half of the 50 million Americans who could benefit from them actually take statins.

Mild muscle pain occurs slightly more often with statins than with a placebo, but this is not always caused by the drug itself. Serious muscle disorders linked to statins remain extremely rare, with a risk of just 0.04% over ten years, even when the risk is increased tenfold.

Despite their benefits, around 40% of patients stop taking statins within three months. Many overestimate the likelihood of side effects compared to other medications. These side effects are often dose-related and can be managed or reduced. The new tool aims to provide clearer risk assessments for individual patients. By addressing concerns about side effects, clinicians hope to improve adherence and ensure more people benefit from statin therapy. The overall risk of severe muscle disorders remains minimal.